Update (October 20): The US Food and Drug Administration granted an emergency use authorization for a booster dose of Novavax’s COVID-19 vaccine yesterday. The booster is available to adults 6 months after they have completed their primary vaccination series with any authorized or approved COVID-19 vaccine.
Update (July 20): On Tuesday (July 19), the US Centers for Disease Control and Prevention officially endorsed Novavax’s COVID-19 vaccine for use in adults. “If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated,” CDC Director Rochelle Walensky says in the agency’s media statement.
On Wednesday (July 13), the US Food and Drug Administration granted an emergency use authorization for the COVID-19 vaccine developed by the Maryland-based biotech firm Novavax. If the Centers for Disease Control and Prevention (CDC) recommends the two-dose, ...
